Exosomal miR-181b-5p Downregulation in Ascites Serves as a Potential Diagnostic Biomarker for Gastric Cancer-associated Malignant Ascites|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Purpose: Peritoneal carcinomatosis in gastric cancer (GC) patients results in extremelypoor prognosis. Malignant ascites samples are the most appropriate biological material touse to evaluate biomarkers for peritoneal carcinomatosis. This study identified exosomalMicroRNAs (miRNAs) differently expressed between benign liver cirrhosis-associated ascites(LC-ascites) and malignant gastric cancer-associated ascites (GC-ascites), and validated theirrole as diagnostic biomarkers for GC-ascites.

Materials and Methods: Total RNA was extracted from exosomes isolated from 165 ascitessamples (73 LC-ascites and 92 GC-ascites). Initially, microarrays were used to screen theexpression levels of 2,006 miRNAs in the discovery cohort (n=22). Subsequently, quantitativereverse transcriptase-polymerase chain reaction (qRT-PCR) analyses were performed tovalidate the expression levels of selected exosomal miRNAs in the training (n=70) andvalidation (n=73) cohorts. Furthermore, carcinoembryonic antigen (CEA) levels weredetermined in ascites samples.

Results: The miR-574-3p, miR-181b-5p, miR-4481, and miR-181d were significantlydownregulated in the GC-ascites samples compared to the LC-ascites samples, and miR-181b-5p showed the best diagnostic performance for GC-ascites (area under the curve[AUC]=0.798 and 0.846 for the training and validation cohorts, respectively). The diagnosticperformance of CEA for GC-ascites was improved by the combined analysis of miR-181b-5pand CEA (AUC=0.981 and 0.946 for the training and validation cohorts, respectively).

Conclusions: We identified exosomal miRNAs capable of distinguishing between non-malignant and GC-ascites, showing that the combined use of miR-181b-5p and CEA couldimprove diagnosis.

번역하기

참고문헌 (Reference)

1 Li X, "miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3" 9 : 824-833, 2011

2 Shi ZM, "miRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas" 19 : 552-560, 2013

3 Vaksman O, "miRNA profiling along tumour progression in ovarian carcinoma" 15 : 1593-1602, 2011

4 Wang B, "miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients" 421 : 4-8, 2012

5 Zhu FL, "Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites" 16 : 719-722, 2015

6 Jung M, "The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites" 136 : 517-526, 2010

7 Zhou Q, "Smad2/3/4 pathway contributes to TGF-β-induced miRNA-181b expression to promote gastric cancer metastasis by targeting Timp3" 39 : 453-466, 2016

8 Huang S, "Serum microRNA expression profile as a diagnostic panel for gastric cancer" 46 : 811-818, 2016

9 Gui J, "Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies" 120 : 183-193, 2011

10 Vuppalanchi R, "Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis" 8 : e74471-, 2013